The Boston Scientific AcoArt Drug-Coated Balloon (REF ORC06100BG) is a paclitaxel drug-coated percutaneous transluminal angioplasty (PTA) balloon catheter designed for peripheral vascular intervention. This configuration features a 6.0 mm balloon diameter, 100 mm balloon length, and a 130 cm working catheter length, engineered to deliver antirestenotic therapy directly to the target vessel wall during dilatation.
Key Features
Paclitaxel drug-coated balloon surface intended to inhibit neointimal hyperplasia
Balloon diameter: 6.0 mm
Balloon length: 100 mm
Catheter working length: 130 cm
Introducer sheath compatibility: 6 Fr
Guidewire compatibility: 0.035 inch (per standard AcoArt platform; confirm with IFU)
Low-profile balloon design to support trackability in tortuous peripheral anatomy
Radiopaque markers to aid fluoroscopic positioning
Clinical Applications
Percutaneous transluminal angioplasty of stenotic or occlusive lesions in peripheral arteries
Treatment of de novo and restenotic lesions in the superficial femoral and popliteal arteries (per approved indications in applicable regions)
Adjunctive use following predilatation in peripheral endovascular procedures
Intended for use by trained interventional specialists in accordance with the manufacturer Instructions for Use
Product Information
Brand: Boston Scientific
Product line: AcoArt Drug-Coated Balloon
Category: Peripheral Balloon Catheters
REF / UPN: ORC06100BG
Configuration code: 6.0 mm x 100 mm, 130 cm, 6 Fr
Sterility: Sterile, single-use device (confirm packaging on IFU)
Storage and handling: Not specified in the located sources
Regulatory status: Refer to local regulatory documentation for market-specific approvals